SARS-CoV-2-specific immune response and the pathogenesis of COVID-19

E Gusev, A Sarapultsev, L Solomatina… - International journal of …, 2022 - mdpi.com
The review aims to consolidate research findings on the molecular mechanisms and
virulence and pathogenicity characteristics of coronavirus disease (COVID-19) causative …

Pregnancy and COVID-19

EAN Wastnedge, RM Reynolds… - Physiological …, 2020 - journals.physiology.org
There are many unknowns for pregnant women during the coronavirus disease 2019
(COVID-19) pandemic. Clinical experience of pregnancies complicated with infection by …

Animal models for COVID-19

C Muñoz-Fontela, WE Dowling, SGP Funnell, PS Gsell… - Nature, 2020 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the aetiological agent of
coronavirus disease 2019 (COVID-19), an emerging respiratory infection caused by the …

Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study

G Grasselli, T Tonetti, A Protti, T Langer… - The lancet Respiratory …, 2020 - thelancet.com
Background Patients with COVID-19 can develop acute respiratory distress syndrome
(ARDS), which is associated with high mortality. The aim of this study was to examine the …

COVID-19-associated coagulopathy and disseminated intravascular coagulation

H Asakura, H Ogawa - International journal of hematology, 2021 - Springer
The pathology of coronavirus disease 2019 (COVID-19) is exacerbated by the progression
of thrombosis, and disseminated intravascular coagulation (DIC), and cytokine storms. The …

Obesity and diabetes as high‐risk factors for severe coronavirus disease 2019 (Covid‐19)

Y Zhou, J Chi, W Lv, Y Wang - Diabetes/metabolism research …, 2021 - Wiley Online Library
The outbreak of the coronavirus disease 2019 (Covid‐19) has become an evolving
worldwide health crisis. With the rising prevalence of obesity and diabetes has come an …

Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19

AK Azkur, M Akdis, D Azkur, M Sokolowska… - Allergy, 2020 - Wiley Online Library
As a zoonotic disease that has already spread globally to several million human beings and
possibly to domestic and wild animals, eradication of coronavirus disease 2019 (COVID‐19) …

Cellular host factors for SARS-CoV-2 infection

J Baggen, E Vanstreels, S Jansen, D Daelemans - Nature Microbiology, 2021 - nature.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic has claimed millions of lives
and caused a global economic crisis. No effective antiviral drugs are currently available to …

Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia

D McGonagle, JS O'Donnell, K Sharif… - The Lancet …, 2020 - thelancet.com
The lung pathology seen in patients with coronavirus disease 2019 (COVID-19) shows
marked microvascular thrombosis and haemorrhage linked to extensive alveolar and …

Coagulopathy of coronavirus disease 2019

T Iba, JH Levy, M Levi, JM Connors… - Critical care …, 2020 - journals.lww.com
Objectives: Recent studies have reported a high prevalence of thrombotic events in
coronavirus disease 2019. However, the significance of thromboembolic complications has …